Ingevity (NGVT) Stock Price
Ingevity Price
Over the last 13 years Ingevity grew revenue by 1.7% annually, reaching 1.17 B USD. Earnings per share have grown at 7.1% per year over the last 10 years. For Ingevity, the net margin of -14.3% is down versus 8.5% a few years ago. The consensus 12-month price target for Ingevity is 82.50 USD, about 13.9% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
Ingevity stock price
Ingevity business model & stock analysis
Frequently asked questions about Ingevity
The business model of Ingevity Corp revolves around supplying specialty chemicals and high-performance carbon materials. As a leading global provider, Ingevity focuses on addressing crucial environmental, energy, and purification challenges through innovative solutions. With a diverse portfolio, the company serves various sectors including automotive, construction, energy, and industrial markets. Ingevity Corporation leverages its advanced technologies and expertise to enhance the performance, efficiency, and sustainability of its customers' products. By consistently delivering exceptional value and sustainable solutions, Ingevity Corp has established itself as a trusted partner in the specialty chemicals industry.
Ingevity Corp is primarily active in the chemical industry.
The main competitors of Ingevity Corp in the market are Calgon Carbon Corporation, Cabot Corporation, and Kuraray Co., Ltd.
Ingevity Corp has a rich history and background in the chemical industry. The company was founded in 2016 and is headquartered in North Charleston, South Carolina. Ingevity Corp specializes in developing and manufacturing specialty chemicals and carbon materials that are used in a wide range of industries. With a focus on sustainability and innovation, Ingevity Corp continues to grow and expand its product offerings. The company has a strong global presence, serving customers in more than 100 countries. Ingevity Corp strives to deliver high-quality solutions and enhance the performance of various products, making it a key player in the chemical market.
Ingevity Corp has achieved several significant milestones in its history. Firstly, the company was spun off from WestRock Company in 2016, establishing itself as an independent entity. In 2017, Ingevity completed the acquisition of Georgia-Pacific's pine chemicals business, expanding its product portfolio and market presence. Additionally, in 2019, Ingevity acquired the Capa™ caprolactone division from Perstorp, enhancing its offerings in specialty chemicals. These strategic moves have propelled Ingevity Corp's growth and solidified its position as a leading provider of specialty chemicals and materials.
Ingevity Corp is primarily present in the United States.
Ingevity Corp represents a strong commitment to sustainable practices and innovative solutions. The company focuses on three key values: Integrity, Innovation, and Collaboration. Ingevity is dedicated to conducting business with honesty and transparency, always adhering to the highest ethical standards. With a focus on continuous improvement and strategic investments in research and development, Ingevity strives to deliver innovative and sustainable solutions to its customers. Moreover, the company believes in the power of collaboration and partnerships to drive growth and create long-term value. Overall, Ingevity Corp is dedicated to making a positive impact on its stakeholders, the environment, and the communities it serves.
Analysts currently set an average price target of 82.50 USD for the Ingevity stock (median: 82.50 USD), implying +13.9 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Ingevity stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Ingevity to generate revenue of 1.11 B USD and earnings per share of 5.45 USD.
Converted at the current exchange rate, the Ingevity share trades at 64.39 EUR (72.44 USD).
The Ingevity share (NGVT) is listed on 3 stock exchanges, including: NYSE (NGVT), Frankfurt (IGX.F), München (IGX.MU).
Ingevity Corp is a leading company in the production of specialty materials and chemicals that focuses on providing solutions for a more sustainable future. The company is based in North Charleston, South Carolina, USA, and has branches in various parts of the world. The company's core business consists of three main divisions: Performance Materials, Specialty Chemicals, and Carbon Materials. The Performance Materials division focuses on the production of materials used in various applications such as automotive, aerospace, construction, electronics, and energy industries. The Specialty Chemicals division produces high-quality chemicals and substances used in agriculture, food and beverage, construction and coating, and pharmaceutical industries. The Carbon Materials division focuses on the production of carbon products used in the aerospace industry, automotive industry, wind turbine construction, and electronics industry. Ingevity Corp also offers a wide range of products marketed under its Adsorbents brand, including bio-based resins, activated carbon, and other adsorbents used in various applications such as emission control in the automotive industry or water purification. The company also has a strong presence in the oil and gas products market, where it uses its adsorbents and other specialty products to assist in the production and transportation of energy resources. Ingevity Corp is committed to innovation and sustainability and aims to develop products that contribute to environmental protection. The company has developed a number of sustainability and corporate social responsibility initiatives, such as the use of renewable energy sources, reducing energy consumption, transitioning to bio-based raw materials, and innovations that help reduce CO2 footprint. The company also aims to expand its global presence through partnerships and acquisitions to strengthen its position as a leading provider of specialty materials and chemicals in the market. Overall, Ingevity Corp's business model is focused on offering high-quality and innovative products and services that contribute to shaping a more sustainable future while ensuring profitable growth.
The expected revenue of Ingevity is 1.11 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Ingevity is 194.69 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Ingevity is currently 13.28. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ingevity stock.
The price-to-sales ratio (P/S) of Ingevity is currently 2.32. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ingevity stock.
The Eulerpool Quality Score for Ingevity is 1/10.
The ISIN of Ingevity is US45688C1071. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Ingevity is A2AHZS. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Ingevity is NGVT. The ticker symbol is used to trade Ingevity shares on the stock exchange.
Ingevity stock
Ingevity Peer Group
Ingevity Ticker
Ingevity FIGI
All fundamentals and in-depth analysis of Ingevity
Our stock analysis for Ingevity stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ingevity. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.